These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1999028

  • 1. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G.
    Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat.
    Edwall B, Gazelius B, Fazekas A, Theodorsson-Norheim E, Lundberg JM.
    Acta Physiol Scand; 1985 Oct; 125(2):253-64. PubMed ID: 2866663
    [Abstract] [Full Text] [Related]

  • 3. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

  • 4. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM, Modin A.
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [Abstract] [Full Text] [Related]

  • 6. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
    Franco-Cereceda A, Matran R, Alving K, Lundberg JM.
    Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
    [Abstract] [Full Text] [Related]

  • 7. Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
    Pernow J, Lundberg JM, Kaijser L.
    Clin Physiol; 1989 Feb; 9(1):67-75. PubMed ID: 2706916
    [Abstract] [Full Text] [Related]

  • 8. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Feb; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 9. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M, Michalkiewicz M, Huffman L, Hedge GA.
    Peptides; 1993 Feb; 14(6):1179-86. PubMed ID: 8134299
    [Abstract] [Full Text] [Related]

  • 10. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J, Kahan T, Hjemdahl P, Lundberg JM.
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
    [Abstract] [Full Text] [Related]

  • 12. Nonadrenergic sympathetic vascular control of the human forearm in hypertension: possible involvement of neuropeptide Y.
    Kahan T, Taddei S, Pedrinelli R, Hjemdahl P, Salvetti A.
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):587-92. PubMed ID: 1380602
    [Abstract] [Full Text] [Related]

  • 13. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ, Einstein R, Potter EK, Richardson DP.
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [Abstract] [Full Text] [Related]

  • 14. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S, Yang CL, Chen X, Naes L, Cox BF, Westfall T.
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [Abstract] [Full Text] [Related]

  • 15. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
    Cockcroft JR, Clarke JG, Webb DJ.
    Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V, Edvinsson L, Burnstock G.
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [Abstract] [Full Text] [Related]

  • 17. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E, Mori H, Chujo M, Yamakawa A, Mohammed MU, Shinozaki Y, Tobita K, Sekka T, Ito K, Nakazawa H.
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.